The Senior CRA performs monitoring activities related to initiation, conduct (recruitment, quality data collection) and timely completion of Phase I-IV Pharma clinical trials within the country. The Senior CRA is responsible to deliver data within timelines and required quality standard, and adherence to monitoring procedures in accordance with ICH/GCP and US CFR and company SOPs. This position will require 80% travel.

As the Senior Director of Medical Affairs Statistics, you will play a pivotal role in leading a dynamic team focused on evidence generation and health technology assessment. This position is critical to ensuring the development and dissemination of scientific evidence of clinical outcomes and product value for marketplace stakeholders. With your expertise, you will impact evidence strategy and oversee analytics which contribute directly to our organization’s success.

This position reports into the Safety Operations Product Leadership team which is part of the International Strategy & Safety Operations (ISSO) function in Patient Safety. The Sr. Product Manager oversees the accuracy, completeness and timeliness of all Safety Operations scientific activities and deliverables for Oncology and/or focused disease state. The Sr. Product Manager is the point of contact for Product Safety Teams and contextualization of Adverse Event data.

This position supports the Safety Operations organization to achieve its mission of improving patient lives by delivering high quality, and timely adverse event management and through driving industry leading ICSR operations, ICSR standards and technology at AbbVie. The Manager, Office of Safety Operations sits in the ICSR Compliance department within the Safety Operations function.

The Vaccines Markets team needs a Senior Associate to lead our work in Latin America and the Caribbean (LAC). Initially this will entail three areas of work: developing evidence-based target for vaccine capacity in the LAC region, assessing the financing requirements of regional manufacturers, and interviewing vaccine manufacturers to collate and track the available products from manufacturers in the region to act as a reference database of available vaccine technologies in each region.

Natera is seeking a strategic and visionary leader to serve as Vice President, Oncology Medical, leading the Medical Affairs activities for our Oncology Business Unit. Reporting directly to the Chief Medical Officer, this individual will oversee a team of Medical Directors and collaborate with the Medical Science Liaisons (MSLs) team, with the Genetic Counselors (GCs) team and Clinical Trial Operations staff. The VP will act as a scientific ambassador for the Oncology Business Unit, driving medical strategy, shaping clinical trial designs, and building relationships with key stakeholders in oncology.

Work closely with biostatistics to support the analysis of clinical data across multiple studies. Develop novel approaches to data visualization. Provide data analysis support to various safety workstreams. Support the medical communications across multiple clinical studies. Support the development of tactics on the Global Evidence Generation team in alignment with product strategy.

The Summer Intern supports the function of their designated department within Navitus, Lumicera or Epiphany. Conduct medication reconciliation with members and adherence interventions. Discuss changes to benefit plan with members, prepare and present research projects. Review and update algorithms and call scripts. Compile valuable Subject Matter Expert (SME) topics and documentation by working with team members, create clear and concise documentation.

The MSL will represent Corcept to the highest ethical and professional standards. The MSL will demonstrate strong clinical acumen and ability to engage in scientific discussions with TLs and HCPs on Corcept’s therapeutic areas, and products and display the MSL Core Competencies. The MSL will engage in scientific discussion with thought leaders (TLs) and HCPs to build knowledge and advocacy for Cushing’s syndrome and Corcept’s FDA approved product(s).

The Medical Science Liaison (MSL) will foster strong relationships with key opinion leaders (KOLs) and support the scientific and clinical strategy of Orca Bio's innovative therapies. As a critical link between Orca Bio and external healthcare providers (HCPs), the MSL will establish strong professional collaborations with investigators and other HCPs within the designated territory. The MSL will also serve as an active leader and contributor on projects in support of the Medical Affairs Strategic Plan.